ACR 2021 Archives - Medical Conferences

Home > Rheumatology > ACR 2021

Read the full Report (pdf)

American College of Rheumatology
03–10 November 2021

Featured articles

Letter from the Editor

Editor

Prof. Dennis McGonagle, University of Leeds, United Kingdom

Conference

EULAR 2021

14 January, 2022 11:14

ACR 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

ACR 2021

22 November, 2021 16:18

Online First

Late-Breaking Abstracts

Vaccine booster improves immune response in patients treated with rituximab

Presented By

Prof. Michael Bonelli, Medical University of Vienna, Austria

Conference

ACR 2021

14 January, 2022 11:07

IL-17 inhibition showing efficacy in GCA in phase 2 trials

Presented By

Prof. Jens Thiel, Medical University Graz, Austria

Trial

Phase 2, TitAIN

Conference

ACR 2021

14 January, 2022 11:05

Spotlight on Rheumatoid Arthritis

Cycling JAK inhibitors shows similar effectiveness to switching to a bDMARD in difficult-to-treat RA

Presented By

Dr Manuel Pombo-Suarez, Hospital Clinico Universitario de Santiago De Compostela, Spain

Trial

JAK-pot

Conference

ACR 2021

14 January, 2022 11:03

Pre-existing heart failure affects safety of hydroxychloroquine in RA patients

Presented By

Dr Elvira D’Andrea, Brigham and Women’s Hospital, MA, USA

Conference

ACR 2021

14 January, 2022 11:01

Patients with RA-associated interstitial lung disease benefit from antifibrotic agent

Presented By

Prof. Joshua J. Solomon, National Jewish Health, CO, USA

Trial

Phase 2, TRAIL1

Conference

ACR 2021

14 January, 2022 10:59

Ultra-low dosing of rituximab in RA is a viable treatment option

Presented By

Mr Nathan den Broeder, Sint Maartenskliniek, the Netherlands

Trial

REDO

Conference

ACR 2021

14 January, 2022 10:58

Kidney disease and hydroxychloroquine dose are risk factors for developing retinopathy

Presented By

Dr April Jorge, Massachusetts General Hospital, MA, USA

Conference

ACR 2021

14 January, 2022 10:55

More pros than cons for the use of statins in RA

Presented By

Dr Gulsen Ozen, University of Nebraska Medical Center, NE, USA

Conference

ACR 2021

14 January, 2022 10:54

Psoriatic Arthritis: Novel Developments

Selective IL-23 inhibition: a new option in active PsA

Presented By

Prof. Andrew Östör, Monash University, Australia

Trial

Phase 3, KEEPsAKE 1, KEEPsAKE 2

Conference

ACR 2021

14 January, 2022 10:52

Ustekinumab: highly efficacious in PSA independent of methotrexate

Presented By

Dr Michaela Köhm, Goethe-University Frankfurt, Germany

Conference

ACR 2021

14 January, 2022 10:48

COVID-19: What You Need to Know

Vaccinated rheumatic patients carry increased risk for COVID-19 breakthrough infections

Presented By

Prof. Jasvinder Singh, University of Alabama at Birmingham, AL, USA

Conference

ACR 2021

14 January, 2022 10:47

B-cell depleting medication increases COVID-19 breakthrough infection outcome risk

Presented By

Prof. Jean Liew, Boston University, MA, USA

Conference

ACR 2021

14 January, 2022 10:45

COVID-19 mRNA vaccine safe and tolerable in adults with autoimmune disease

Presented By

Dr Inés Colmegna, McGill University Health Centre, Canada

Conference

ACR 2021

14 January, 2022 10:06

SLE Treatment: What Is New

Iberdomide: an upcoming new treatment possibility in lupus erythematosus

Presented By

Prof. Joan Merrill, Oklahoma Medical Research Foundation, OK, USA

Trial

Phase 2

Conference

ACR 2021

14 January, 2022 10:04

Sequential rituximab after belimumab does not improve disease control in SLE

Presented By

Prof. Cynthia Aranow, Feinstein Institutes for Medical Research, NY, USA

Trial

Phase 3, BLISS-BELIEVE

Conference

ACR 2021

14 January, 2022 10:02

Lupus patients less protected by COVID-19 vaccine

Presented By

Dr Peter Izmirly, New York University Grossman School of Medicine, NY, USA

Conference

ACR 2021

14 January, 2022 10:00

Late-Breaking Posters

Promising results in uric acid-lowering in gout patients with a new xanthine oxidase inhibitor

Presented By

Prof. Robert Terkeltaub, University of California San Diego, CA, USA

Trial

Phase 2

Conference

ACR 2021

14 January, 2022 09:58

Laboratory and clinical signs 24h after hospitalisation predict MIS-C in children

Presented By

Dr Matthew Clark, Vanderbilt University Medical Center, TN, USA

Conference

ACR 2021

14 January, 2022 09:55

Featured articles

CONTENTS

Online First

Late-Breaking Abstracts

Spotlight on Rheumatoid Arthritis

Psoriatic Arthritis: Novel Developments

COVID-19: What You Need to Know

SLE Treatment: What Is New

Late-Breaking Posters